Interim assessment by circulating tumor DNA in primary mediastinal large B-cell lymphoma: a multicenter LYSA study.

Saved in:
Bibliographic Details
Title: Interim assessment by circulating tumor DNA in primary mediastinal large B-cell lymphoma: a multicenter LYSA study.
Authors: Camus V; Department of Hematology, Centre Henri Becquerel, Rouen, France.; INSERM U1245, University of Rouen, Rouen, France.; Laboratory of Experimental Hematology, Institute of Oncology Research, Università della Svizzera italiana, Bellinzona, Switzerland., Krzisch D; Department of Hemato-oncology, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Université de Paris, Paris, France., Bruscaggin A; Laboratory of Experimental Hematology, Institute of Oncology Research, Università della Svizzera italiana, Bellinzona, Switzerland., Lévêque E; Clinical Research Unit, Centre Henri Becquerel, Rouen, France., Viennot M; INSERM U1245, University of Rouen, Rouen, France., Fornecker LM; Department of Hematology, Strasbourg University Hospital, Strasbourg, France., Cheminant M; Department of Hematology, Hôpital Necker, Assistance Publique-Hôpitaux de Paris, Université de Paris Cité, Paris, France., Bailly S; Department of Hematology, Clermont-Ferrand University Hospital, Clermont-Ferrand, France., Morschhauser F; Department of Hematology, Claude Huriez Hospital, Lille University Hospital, Lille, France., Feugier P; Department of Hematology, Hôpital de Brabois, Nancy University Hospital, Nancy, France., Choquet S; Department of Hematology, Pitié-Salpêtrière University Hospital, Assistance Publique-Hôpitaux de Paris, and Sorbonne Université, Paris, France., Durot E; Department of Hematology, Reims University Hospital, Reims, France., Carras S; Molecular Biology and Hematology Departments, University Hospital, Institute For Advanced Biosciences (INSERM U1209, CNRS UMR 5309), Université Grenoble Alpes, Grenoble, France., Delette C; Department of Clinical Hematology, Amiens University Hospital, Amiens, France., Damaj GL; Department of Hematology, Caen University Hospital, Caen, France., Waultier-Rascalou A; Department of Hematology, Nimes University Hospital, Nimes, France., Lebreton P; Department of Hematology, Centre Henri Becquerel, Rouen, France.; Jacques Monod Hospital, Groupe Hospitalier du Havre, Montivilliers, France., Le Du K; Hôpital Privé du Confluent, Nantes, France., Galtier J; Hematology and Cellular Therapy Department, University Hospital of Bordeaux, France., Houot R; CHU Rennes, Department of Hematology, University of Rennes, INSERM U1236, EFS, Rennes, France., Morineau N; Centre Hospitalier Départemental de Vendée, La Roche-sur-Yon, France., Laribi K; Department of Hematology, Centre Hospitalier du Mans, Le Mans, France., Lebras L; Department of Hematology, Leon Berard Cancer Center, Lyon, France., Oberic L; Department of Hematology, Institut Universitaire du Cancer, Toulouse-Oncopole, Toulouse, France., Amorim S; Department of Hematology, Hôpital Saint Vincent de Paul, Lille, France., Bocchetta S; Laboratory of Experimental Hematology, Institute of Oncology Research, Università della Svizzera italiana, Bellinzona, Switzerland., Viailly PJ; INSERM U1245, University of Rouen, Rouen, France., Rainville V; INSERM U1245, University of Rouen, Rouen, France., Ruminy P; INSERM U1245, University of Rouen, Rouen, France., Caillot M; INSERM U1245, University of Rouen, Rouen, France., Terzi di Bergamo L; Laboratory of Experimental Hematology, Institute of Oncology Research, Università della Svizzera italiana, Bellinzona, Switzerland., Piffaretti D; Laboratory of Experimental Hematology, Institute of Oncology Research, Università della Svizzera italiana, Bellinzona, Switzerland., Pirosa MC; Laboratory of Experimental Hematology, Institute of Oncology Research, Università della Svizzera italiana, Bellinzona, Switzerland., Salehi M; Laboratory of Experimental Hematology, Institute of Oncology Research, Università della Svizzera italiana, Bellinzona, Switzerland., Forestieri G; Department of Hemato-oncology, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Université de Paris, Paris, France., Drieux F; INSERM U1245, University of Rouen, Rouen, France.; Department of Pathology, Centre Henri Becquerel, Rouen, France., Veresezan EL; INSERM U1245, University of Rouen, Rouen, France.; Department of Pathology, Centre Henri Becquerel, Rouen, France., Traverse-Glehen A; Department of Pathology, Hospices Civils de Lyon, Pierre-Bénite, France., Donzel M; Department of Pathology, Hospices Civils de Lyon, Pierre-Bénite, France., Burel L; Clinical Research Unit, Centre Henri Becquerel, Rouen, France., Bohers E; INSERM U1245, University of Rouen, Rouen, France., Lanic MD; INSERM U1245, University of Rouen, Rouen, France., Penther D; INSERM U1245, University of Rouen, Rouen, France.; Laboratory of Genetic Oncology, Centre Henri Becquerel, Rouen, France., Becker S; Department of Nuclear Medicine and QuantIF-LITIS/AIMS, University of Rouen, Centre Henri Becquerel, Rouen, France., Decazes P; Department of Nuclear Medicine and QuantIF-LITIS/AIMS, University of Rouen, Centre Henri Becquerel, Rouen, France., Tonnelet D; Department of Nuclear Medicine and QuantIF-LITIS/AIMS, University of Rouen, Centre Henri Becquerel, Rouen, France., Draye-Carbonnier S; Department of Nuclear Medicine and QuantIF-LITIS/AIMS, University of Rouen, Centre Henri Becquerel, Rouen, France., Tilly H; Department of Hematology, Centre Henri Becquerel, Rouen, France.; INSERM U1245, University of Rouen, Rouen, France., Jardin F; Department of Hematology, Centre Henri Becquerel, Rouen, France.; INSERM U1245, University of Rouen, Rouen, France., Rossi D; Laboratory of Experimental Hematology, Institute of Oncology Research, Università della Svizzera italiana, Bellinzona, Switzerland.; Clinic of Hematology, Oncology Institute of Southern Switzerland, EOC, Bellinzona, Switzerland.; Division of Hematology, Faculty of Biomedicine, Università della Svizzera italiana, Lugano, Switzerland., Sesques P; Department of Hematology, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon, Université Claude Bernard Lyon 1, Lyon, France.
Source: Blood advances [Blood Adv] 2026 Jul 14; Vol. 10 (13), pp. 4455-4467.
Publication Type: Journal Article; Multicenter Study; Observational Study
Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2473-9537
DOI:10.1182/bloodadvances.2025019108